In a recent study published in the Journal of American Medical Association (JAMA) Oncology, researchers from California investigated the diagnostic outcomes of concurrent sequencing of ...

Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease ALISO VIEJO, Calif., February 02, 2026--(BUSINESS WIRE)--Ambry Genetics, a leader in ...

Cancer is most treatable in its early stages, so finding innovative and non-invasive methods to diagnose cancer early on is crucial for fighting the disease. Liquid biopsies, which require just a ...

VANCOUVER, British Columbia -- The novel multitarget stool RNA test (ColoSense) showed high sensitivity for detecting colorectal neoplasia among adults ages 45 and older, according to the phase III ...

Two separate laboratory breakthroughs have produced RNA molecules that can build copies of themselves or assemble functional structures without any help from proteins or DNA. These results offer the ...

Researchers at The Institute of Cancer Research have found a dual genetic test is more accurate than the traditional approach in identifying multiple myeloma patients who may be at an elevated risk of ...

A single positive HIV viral load test often falsely identified HIV infection in people who were using long-acting cabotegravir (Apretude) for preexposure prophylaxis (PrEP), according to results from ...

Dr. Kayvan Zainabadi (center) is working with colleagues in Pune, India, to test the RNA-based TB diagnostic he is developing. From left: Dr. Mandar Paradkar (co-PI, pediatrician), Vidyulata Kamble, ...

The novel Cleavage High-throughput Assay (CHiTA) developed at Penn State provides a scarless method to characterize thousands of diverse small self-cleaving RNA enzymes, called twister ribozymes, in a ...

A lab is developing more accurate and powerful liquid biopsy technologies that take advantage of signals from RNA 'dark matter,' an understudied area of the genome. Cancer is most treatable in its ...